Trinity compound research profile
DSIP
DSIP stands for Delta Sleep-Inducing Peptide. It's a tiny chain of 9 amino acids (the building blocks of proteins) that scientists first found in the...
Research overview
DSIP stands for Delta Sleep-Inducing Peptide. It's a tiny chain of 9 amino acids (the building blocks of proteins) that scientists first found in the blood of rabbits back in the 1970s, while the rabbits were being made to sleep using electrical stimulation (Schoenenberger & Monnier, PNAS 1977). So it's a naturally occurring substance, not something invented in a lab from scratch — but nobody has found the exact 'lock' (receptor) in the body that it's supposed to fit into, which is unusual for a hormone-like molecule.
Mechanism under study
Think of DSIP as a message with no confirmed mailbox. Scientists believe it nudges the brain toward deep, 'slow-wave' sleep (the deepest, most restorative stage of sleep) and may also tweak hormone systems in the brain that control stress hormones and growth hormone release (DSIP, slow-wave sleep and GH release, PNAS 1988). It may also have some protective effect on brain cells after injuries like seizures or strokes in animal studies (intranasal DSIP in stroke recovery). But exactly how it does any of this is still a mystery — scientists describe its effects without fully knowing the mechanism.
Human evidence summary
In the 1980s, small groups of people with insomnia were given DSIP through injections and reported better sleep after a single dose, and even better results after repeated use over time (DSIP in insomnia, Eur Neurol 1984; Experientia 1981; Eur Neurol 1987). But these studies were tiny, done mostly by one research group, weren't well controlled (meaning there wasn't a solid comparison group), and have never been redone with modern, rigorous methods. So while the early results sound promising, they haven't been confirmed since.
Preclinical evidence summary
In rats, DSIP appeared to boost deep sleep and affect the release of growth hormone. It also showed possible protective effects on the brain in animal models of seizures and stroke, including when given through the nose (intranasal DSIP stroke study). These are early-stage findings in animals, not proof it works the same way in people.
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.